Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2298)
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
784
Price
$138.18
Total Value
$108.33K
Shares Held After
32,162
% of Holdings
2.4%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
2,054
Price
$137.61
Total Value
$282.64K
Shares Held After
32,946
% of Holdings
5.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
9,939
Price
$0.37
Total Value
$3.68K
Shares Held After
331,414
% of Holdings
2.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
139,686
Price
$0.37
Total Value
$51.68K
Shares Held After
4,657,664
% of Holdings
2.9%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
124,893
Price
$8.89
Total Value
$1.11M
Shares Held After
16,763,043
% of Holdings
0.7%
Guardant Health, Inc. (GH)
Tariq Musa — Director
Shares
116
Price
$130.19
Total Value
$15.10K
Shares Held After
8,796
% of Holdings
1.3%
Dermata Therapeutics, Inc. (DRMA)
Scott Kathleen D. — Director
Shares
11
Price
$1.19
Total Value
$13.09
Shares Held After
0
% of Holdings
100.0%
Aura Biosciences, Inc. (AURA)
Gibney Anthony S — Chief Financial and Business Officer.
Shares
12,824
Price
$6.42
Total Value
$82.33K
Shares Held After
265,354
% of Holdings
4.6%
Guardant Health, Inc. (GH)
Kalia Kumud — Chief Information Officer
Shares
600
Price
$131.08
Total Value
$78.65K
Shares Held After
40,814
% of Holdings
1.4%
Guardant Health, Inc. (GH)
Kalia Kumud — Chief Information Officer
Shares
600
Price
$130.76
Total Value
$78.46K
Shares Held After
41,414
% of Holdings
1.4%
Stevanato Group S.p.A. (STVN)
MOREL DONALD E JR — Director
Shares
1,493
Price
$17.09
Total Value
$25.52K
Shares Held After
37,424
% of Holdings
3.8%
Stevanato Group S.p.A. (STVN)
Balachandran Madhavan — Director
Shares
1,493
Price
$17.09
Total Value
$25.52K
Shares Held After
69,458
% of Holdings
2.1%
Stevanato Group S.p.A. (STVN)
FEDERICI WILLIAM J — Director
Shares
1,493
Price
$17.09
Total Value
$25.52K
Shares Held After
26,991
% of Holdings
5.2%
Stevanato Group S.p.A. (STVN)
Flynn Karen — Director
Shares
1,493
Price
$17.09
Total Value
$25.52K
Shares Held After
5,757
% of Holdings
20.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
9,890
Price
$23.81
Total Value
$235.49K
Shares Held After
57,095
% of Holdings
14.8%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,096
Price
$24.41
Total Value
$99.98K
Shares Held After
38,378
% of Holdings
9.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
300
Price
$213.54
Total Value
$64.06K
Shares Held After
249,352
% of Holdings
0.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
500
Price
$212.42
Total Value
$106.21K
Shares Held After
249,652
% of Holdings
0.2%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
600
Price
$211.34
Total Value
$126.80K
Shares Held After
250,152
% of Holdings
0.2%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
1,750
Price
$210.29
Total Value
$368.01K
Shares Held After
250,752
% of Holdings
0.7%
Arcutis Biotherapeutics, Inc. (ARQT)
LIN SUE-JEAN — Director
Shares
4,946
Price
$24.38
Total Value
$120.59K
Shares Held After
27,567
% of Holdings
15.2%
Stablecoin Development Corp (SDEV)
Kazley Michael John — Director
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Stablecoin Development Corp (SDEV)
Framework Ventures IV L.P. — 10% Owner
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Stablecoin Development Corp (SDEV)
R01 Fund LP — 10% Owner
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
100,000
Price
$17.37
Total Value
$1.74M
Shares Held After
1,412,058
% of Holdings
6.6%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
60,400
Price
$160.17
Total Value
$9.67M
Shares Held After
158,222
% of Holdings
27.6%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
6,657
Price
$16.39
Total Value
$109.08K
Shares Held After
232,457
% of Holdings
2.8%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
3,328
Price
$16.38
Total Value
$54.53K
Shares Held After
239,114
% of Holdings
1.4%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
3,329
Price
$16.39
Total Value
$54.56K
Shares Held After
242,442
% of Holdings
1.4%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
272,322
Price
$45.02
Total Value
$12.26M
Shares Held After
7,388,902
% of Holdings
3.6%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
9,086
Price
$45.02
Total Value
$409.05K
Shares Held After
245,728
% of Holdings
3.6%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
5,538
Price
$60.71
Total Value
$336.21K
Shares Held After
15,437
% of Holdings
26.4%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
96,000
Price
$0.04
Total Value
$4.32K
Shares Held After
93,389,560
% of Holdings
0.1%
DAVITA INC. (DVA)
Waters Kathleen Alyce — Chief Legal & Pub. Affairs Off
Shares
6,455
Price
$209.17
Total Value
$1.35M
Shares Held After
109,194
% of Holdings
5.6%
DAVITA INC. (DVA)
Waters Kathleen Alyce — Chief Legal & Pub. Affairs Off
Shares
8,950
Price
$207.84
Total Value
$1.86M
Shares Held After
115,649
% of Holdings
7.2%
DAVITA INC. (DVA)
Rodriguez Javier — Director
Shares
30,000
Price
$209.50
Total Value
$6.29M
Shares Held After
879,815
% of Holdings
3.3%
CytomX Therapeutics, Inc. (CTMX)
Ogden Christopher — Chief Financial Officer
Shares
1,624
Price
$3.05
Total Value
$4.95K
Shares Held After
295,324
% of Holdings
0.5%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
100
Price
$31.46
Total Value
$3.15K
Shares Held After
135,209
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
2,191
Price
$31.05
Total Value
$68.03K
Shares Held After
135,309
% of Holdings
1.6%
BillionToOne, Inc. (BLLN)
ten Bosch John Roderick — Senior Vice President of Laboratory Operations
Shares
1,416
Price
$101.47
Total Value
$143.68K
Shares Held After
34,968
% of Holdings
3.9%
BillionToOne, Inc. (BLLN)
ten Bosch John Roderick — Senior Vice President of Laboratory Operations
Shares
1,416
Price
$101.47
Total Value
$143.68K
Shares Held After
36,384
% of Holdings
3.7%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
563
Price
$104.32
Total Value
$58.73K
Shares Held After
1,000
% of Holdings
36.0%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,398
Price
$103.63
Total Value
$248.50K
Shares Held After
1,563
% of Holdings
60.5%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,978
Price
$102.60
Total Value
$305.54K
Shares Held After
3,961
% of Holdings
42.9%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,461
Price
$101.37
Total Value
$249.47K
Shares Held After
6,939
% of Holdings
26.2%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
1,000
Price
$100.05
Total Value
$100.05K
Shares Held After
9,400
% of Holdings
9.6%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
600
Price
$98.74
Total Value
$59.25K
Shares Held After
10,400
% of Holdings
5.5%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
230
Price
$104.47
Total Value
$24.03K
Shares Held After
11,000
% of Holdings
2.0%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,889
Price
$103.68
Total Value
$299.54K
Shares Held After
11,230
% of Holdings
20.5%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,816
Price
$102.77
Total Value
$289.41K
Shares Held After
14,119
% of Holdings
16.6%
Showing 1051–1100 of 2298 transactions (page 22 of 46)